RESEARCH TRIANGLE PARK, North Carolina–(BUSINESS WIRE)–IQVIA (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced that it has been appointed the 2022 Market Health and life sciences Partner of the year by Snowflake, the Data Cloud Company.

IQVIA was recognized for its achievements in leveraging Snowflake Data Cloud for IQVIA’s Data-as-a-Service (DaaS) solution, providing customers with rapid access to searchable global health information.

“The IQVIA and Snowflake collaboration brings together leading healthcare and life sciences analytics assets,” said Avinob Roy, IQVIA Vice President and General Manager, Global Information Management. “The combination of these technologies provides customers with faster insights that advance healthcare and accelerate improved healthcare outcomes.”

Using Snowflake technology, IQVIA DaaS eliminates the need for data transformation, giving IQVIA customers the ability to get insights faster from a centralized data hosting and management solution. This collaboration also allows customers to quickly and cost-effectively access centralized information resources from multiple sources in a standardized structure, answer business questions, and reduce the need for costly multi-system integrations.

“IQVIA and Snowflake have made significant progress together in healthcare and life sciences, striving to help our customers apply their data in meaningful ways,” said Kieran Kennedy, Head of Square. market at Snowflake. “This award has been well deserved by IQVIA, and we are excited to continue our journey together to further support IQVIA’s commitment to public health through human data science.”

Learn more about the value of IQVIA and Snowflake here.

About IQVIA

IQVIA (NYSE: IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections in all aspects of healthcare through its analytics, transformational technology, big data resources and deep domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility, enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA does business in more than 100 countries.

IQVIA is a global leader in protecting patient privacy. The company uses a wide variety of technologies and privacy safeguards to protect the privacy of individuals while generating and analyzing information at a scale that helps healthcare actors identify disease patterns and correlate with the precise treatment and therapy needed for best results. IQVIA’s knowledge and execution capabilities help biotechnology, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders harness a deeper understanding of diseases, human behaviors and scientific advances, with the aim of advancing towards treatments. To learn more, visit www.iqvia.com.